A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage damaged p53. This vital tumor inhibitor protein is frequently lost in various types of malignancies, leading https://bookmarksfocus.com/story7720851/mini-antibodies-revive-p53-new-potential-approach-for-malignant-treatment